BioAtla
Why Robinhood?
You can watch BioAtla and buy or sell other stocks, ETFs, and their options commission-free!About BCAB
BioAtla, Inc. engages in the development of novel class of specific and selective antibody-based therapeutics for the treatment of solid tumor cancer. Its CAB portfolio include MABs & ADCS, BA3011, and BA3021.
BCAB Key Statistics
Stock Snapshot
The current BioAtla(BCAB) stock price is $1.26, with a market capitalization of 104.71M. The stock trades at a price-to-earnings (P/E) ratio of -6.42.
On 2026-09-08, BioAtla(BCAB) stock moved within a range of $1.16 to $1.45. With shares now at $1.26, the stock is trading +8.6% above its intraday low and -13.1% below the session's peak.
Trading volume for BioAtla(BCAB) stock has reached 18.85K, versus its average volume of 1.27M.
Over the past 52 weeks, BioAtla(BCAB) stock has traded between a high of $71.50 and a low of $1.16.
Over the past 52 weeks, BioAtla(BCAB) stock has traded between a high of $71.50 and a low of $1.16.
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.